Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 18, 2026 | Blue Shield of California | Diabetes Prevention Program | Criteria changed |
| May 18, 2026 | Blue Shield of California | Dermatologic Applications of Photodynamic Therapy | Criteria changed |
| May 18, 2026 | Blue Shield of California | Dental Anesthesia | Criteria changed |
| May 18, 2026 | Blue Shield of California | Deep Brain Stimulation | Criteria changed |
| May 18, 2026 | Blue Shield of California | Cryoablation of Tumors Located in the Kidney, Lung, Breast, Pancreas, or Bone | Criteria changed |
| May 18, 2026 | Blue Shield of California | Corneal Collagen Cross-linking | Criteria changed |
| May 18, 2026 | Blue Shield of California | Continuous Passive Motion in the Home Setting | Criteria changed |
| May 18, 2026 | Blue Shield of California | Continuous Glucose Monitoring | Criteria changed |
| May 18, 2026 | Blue Shield of California | Cognitive Rehabilitation | Criteria changed |
| May 18, 2026 | Blue Shield of California | Cochlear Implant | Criteria changed |
| May 18, 2026 | Blue Shield of California | Cleft Palate - Dental Related Services | Criteria changed |
| May 18, 2026 | Blue Shield of California | Chemical Peels | Criteria changed |
| May 18, 2026 | Blue Shield of California | Chelation Therapy for Off-Label Uses | Criteria changed |
| May 18, 2026 | Blue Shield of California | Cellular Immunotherapy for Prostate Cancer | Criteria changed |
| May 18, 2026 | Blue Shield of California | Catheter Ablation for Cardiac Arrhythmias | Criteria changed |
| May 18, 2026 | Blue Shield of California | Catheter Ablation as Treatment for Atrial Fibrillation | Criteria changed |
| May 18, 2026 | Blue Shield of California | Carrier Screening for Genetic Diseases | Criteria changed |
| May 18, 2026 | Blue Shield of California | Cardiac Rehabilitation in the Outpatient Setting | Criteria changed |
| May 18, 2026 | Blue Shield of California | Cardiac Applications of Positron Emission Tomography Scanning | Criteria changed |
| May 18, 2026 | Blue Shield of California | Bone Morphogenetic Protein | Criteria changed |
| May 18, 2026 | Blue Shield of California | Bone Mineral Density Studies | Criteria changed |
| May 18, 2026 | Blue Shield of California | Blepharoplasty, Blepharoptosis Repair (Levator Resection) and Brow Lift (Repair of Brow Ptosis) | Criteria changed |
| May 18, 2026 | Blue Shield of California | Bariatric Surgery | Criteria changed |
| May 18, 2026 | Blue Shield of California | Balloon Dilation of the Eustachian Tube | Criteria changed |
| May 18, 2026 | Blue Shield of California | Autonomic Nervous System Testing | Criteria changed |
| May 18, 2026 | Blue Shield of California | Automated Ambulatory Blood Pressure Monitoring for Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure | Criteria changed |
| May 18, 2026 | Blue Shield of California | Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions | Criteria changed |
| May 18, 2026 | Blue Shield of California | Auditory Brainstem Implant | Criteria changed |
| May 18, 2026 | Blue Shield of California | Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer | Criteria changed |
| May 18, 2026 | Blue Shield of California | Aqueous Shunts and Stents for Glaucoma | Criteria changed |
| May 18, 2026 | Blue Shield of California | Allogeneic Pancreas Transplant | Criteria changed |
| May 18, 2026 | Blue Shield of California | Adjustable Cranial Orthoses for Positional Plagiocephaly and Craniosynostoses | Criteria changed |
| May 18, 2026 | Blue Shield of California | Actigraphy | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Trigger Point and Tender Point Injections | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Threshold Electrical Stimulation as a Treatment of Motor Disorders | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Temporomandibular Disorder | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Technologies for the Evaluation of Skin Lesions Suspected of Malignancy | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Surgical Treatment of Sleep Apnea and Snoring | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Subcutaneous Hormone Pellet Implants | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Sphenopalatine Ganglion Block | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Speech Therapy (Outpatient) | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Somatic Biomarker Testing For Immune Checkpoint Inhibitor Therapy (MSIMMR, PD-L1, TMB) | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Self Administered Medications | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Scintimammography and Gamma Imaging of the Breast and Axilla | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Responsive Neurostimulation for the Treatment of Refractory Focal Epilepsy | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Reduction Mammoplasty for Breast-Related Symptoms | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver Tumors | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Proteomic Testing for Targeted Therapy in Non-Small-Cell Lung Cancer | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Proteogenomic Testing for Patients With Cancer | Criteria changed |
| May 18, 2026 | Capital Blue Cross | Preimplantation Genetic Testing | Criteria changed |